Eric Volkman

This REIT has distributed a payout longer than many of its shareholders have been alive.

There's only one way to see the current hot Hollywood blockbuster on a huge screen.

It's effecting a "merger of equals" with a peer. Supernus Pharmaceuticals SUPN began the stock trading week on a high note, announcing a major merger alongside its latest quarterly earnings release.

Key Points It wasn't hard to be bullish, given the strong second-quarter results reported late last week.

Key Points It's one of the top operators in its industry. It also boasts a business model that keeps producing growth.

It posted a very strong quarterly earnings report. The first summer month was a hot one in several respects for C harles Schwab SCHW . Early

The company notched a pair of modest beats in its second quarter. A banner Tuesday for U.S. stocks was also a prosperous one for Vertex Pharmaceuticals VRTX shares.

Key Points While inflated expectations led to an immediate sell-off, investors soon returned to the veteran financial services stock.

They weren't pleased with the big whiffs on analyst second-quarter estimates.

Key Points Its sales rose at a double-digit rate; net profit growth was more modest. There's another development with the company more worth monitoring, however.